These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 27573632)

  • 1. Artemisinin Resistance-Associated K13 Polymorphisms of Plasmodium falciparum in Southern Rwanda, 2010-2015.
    Tacoli C; Gai PP; Bayingana C; Sifft K; Geus D; Ndoli J; Sendegeya A; Gahutu JB; Mockenhaupt FP
    Am J Trop Med Hyg; 2016 Nov; 95(5):1090-1093. PubMed ID: 27573632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012-2013.
    Torrentino-Madamet M; Fall B; Benoit N; Camara C; Amalvict R; Fall M; Dionne P; Ba Fall K; Nakoulima A; Diatta B; Diemé Y; Ménard D; Wade B; Pradines B
    Malar J; 2014 Dec; 13():472. PubMed ID: 25471113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No polymorphisms in K13-propeller gene associated with artemisinin resistance in Plasmodium falciparum isolated from Brazzaville, Republic of Congo.
    Mayengue PI; Niama RF; Kouhounina Batsimba D; Malonga-Massanga A; Louzolo I; Loukabou Bongolo NC; Macosso L; Ibara Ottia R; Kimbassa Ngoma G; Dossou-Yovo LR; Pembet Singana B; Ahombo G; Sekangue Obili G; Kobawila SC; Parra HJ
    BMC Infect Dis; 2018 Oct; 18(1):538. PubMed ID: 30373565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of association between polymorphisms in the K13 gene and the presence of Plasmodium falciparum parasites at day 3 after treatment with artemisinin derivatives in Senegal.
    Madamet M; Kounta MB; Wade KA; Lo G; Diawara S; Fall M; Bercion R; Nakoulima A; Fall KB; Benoit N; Gueye MW; Fall B; Diatta B; Pradines B
    Int J Antimicrob Agents; 2017 Jun; 49(6):754-756. PubMed ID: 28450175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in Kelch 13 Polymorphisms in Plasmodium falciparum, Southern Rwanda.
    Bergmann C; van Loon W; Habarugira F; Tacoli C; Jäger JC; Savelsberg D; Nshimiyimana F; Rwamugema E; Mbarushimana D; Ndoli J; Sendegeya A; Bayingana C; Mockenhaupt FP
    Emerg Infect Dis; 2021 Jan; 27(1):294-296. PubMed ID: 33350925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of artemisinin resistance in Plasmodium falciparum in northwest Benin after 10 years of use of artemisinin-based combination therapy.
    Ogouyèmi-Hounto A; Damien G; Deme AB; Ndam NT; Assohou C; Tchonlin D; Mama A; Hounkpe VO; Moutouama JD; Remoué F; Ndiaye D; Gazard DK
    Parasite; 2016; 23():28. PubMed ID: 27443837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in K13 and falcipain-2 associated with artemisinin resistance are not prevalent in Plasmodium falciparum isolated from Ugandan children.
    Conrad MD; Bigira V; Kapisi J; Muhindo M; Kamya MR; Havlir DV; Dorsey G; Rosenthal PJ
    PLoS One; 2014; 9(8):e105690. PubMed ID: 25144768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study.
    Uwimana A; Umulisa N; Venkatesan M; Svigel SS; Zhou Z; Munyaneza T; Habimana RM; Rucogoza A; Moriarty LF; Sandford R; Piercefield E; Goldman I; Ezema B; Talundzic E; Pacheco MA; Escalante AA; Ngamije D; Mangala JN; Kabera M; Munguti K; Murindahabi M; Brieger W; Musanabaganwa C; Mutesa L; Udhayakumar V; Mbituyumuremyi A; Halsey ES; Lucchi NW
    Lancet Infect Dis; 2021 Aug; 21(8):1120-1128. PubMed ID: 33864801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of artemisinin partial resistance mutations and lack of histidine rich protein-2 and -3 deletions in Plasmodium falciparum infections from Rukara, Rwanda.
    Schreidah C; Giesbrecht D; Gashema P; Young NW; Munyaneza T; Muvunyi CM; Thwai K; Mazarati JB; Bailey JA; Juliano JJ; Karema C
    Malar J; 2024 May; 23(1):150. PubMed ID: 38755607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of the artemisinin resistant marker (K13) in Plasmodium falciparum parasite populations of Grande Comore Island 10 years after artemisinin combination therapy.
    Huang B; Deng C; Yang T; Xue L; Wang Q; Huang S; Su XZ; Liu Y; Zheng S; Guan Y; Xu Q; Zhou J; Yuan J; Bacar A; Abdallah KS; Attoumane R; Mliva AM; Zhong Y; Lu F; Song J
    Parasit Vectors; 2015 Dec; 8():634. PubMed ID: 26667053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escalating
    van Loon W; Schallenberg E; Igiraneza C; Habarugira F; Mbarushimana D; Nshimiyimana F; Ngarambe C; Ntihumbya JB; Ndoli JM; Mockenhaupt FP
    Antimicrob Agents Chemother; 2024 Jan; 68(1):e0129923. PubMed ID: 38092677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Confirmation of Artemisinin Resistance in Plasmodium falciparum from Patient Isolates, Southern Rwanda, 2019.
    van Loon W; Oliveira R; Bergmann C; Habarugira F; Ndoli J; Sendegeya A; Bayingana C; Mockenhaupt FP
    Emerg Infect Dis; 2022 Apr; 28(4):852-855. PubMed ID: 35318931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Single Mutation in K13 Predominates in Southern China and Is Associated With Delayed Clearance of Plasmodium falciparum Following Artemisinin Treatment.
    Huang F; Takala-Harrison S; Jacob CG; Liu H; Sun X; Yang H; Nyunt MM; Adams M; Zhou S; Xia Z; Ringwald P; Bustos MD; Tang L; Plowe CV
    J Infect Dis; 2015 Nov; 212(10):1629-35. PubMed ID: 25910630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited artemisinin resistance-associated polymorphisms in Plasmodium falciparum K13-propeller and PfATPase6 gene isolated from Bioko Island, Equatorial Guinea.
    Li J; Chen J; Xie D; Eyi UM; Matesa RA; Ondo Obono MM; Ehapo CS; Yang L; Yang H; Lin M
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):54-59. PubMed ID: 27054064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular surveillance of drug resistance: Plasmodium falciparum artemisinin resistance single nucleotide polymorphisms in Kelch protein propeller (K13) domain from Southern Pakistan.
    Ghanchi NK; Qurashi B; Raees H; Beg MA
    Malar J; 2021 Apr; 20(1):176. PubMed ID: 33827592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artemisinin resistance-associated markers in Plasmodium falciparum parasites from the China-Myanmar border: predicted structural stability of K13 propeller variants detected in a low-prevalence area.
    He Y; Campino S; Diez Benavente E; Warhurst DC; Beshir KB; Lubis I; Gomes AR; Feng J; Jiazhi W; Sun X; Huang F; Tang LH; Sutherland CJ; Clark TG
    PLoS One; 2019; 14(3):e0213686. PubMed ID: 30883571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium falciparum Kelch 13 mutations and treatment response in patients in Hpa-Pun District, Northern Kayin State, Myanmar.
    Bonnington CA; Phyo AP; Ashley EA; Imwong M; Sriprawat K; Parker DM; Proux S; White NJ; Nosten F
    Malar J; 2017 Nov; 16(1):480. PubMed ID: 29178921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of K13 mutations in Plasmodium falciparum persisting after artemisinin combination therapy treatment of Kenyan children.
    Muwanguzi J; Henriques G; Sawa P; Bousema T; Sutherland CJ; Beshir KB
    Malar J; 2016 Jan; 15():36. PubMed ID: 26801909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insight into k13-propeller gene polymorphism and ex vivo DHA-response profiles from Cameroonian isolates.
    Menard S; Tchoufack JN; Maffo CN; Nsango SE; Iriart X; Abate L; Tsapi MT; Awono-Ambéné PH; Abega Mekongo FA; Morlais I; Berry A
    Malar J; 2016 Nov; 15(1):572. PubMed ID: 27887614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural selection of K13 mutants of Plasmodium falciparum in response to artemisinin combination therapies in Thailand.
    Putaporntip C; Kuamsab N; Kosuwin R; Tantiwattanasub W; Vejakama P; Sueblinvong T; Seethamchai S; Jongwutiwes S; Hughes AL
    Clin Microbiol Infect; 2016 Mar; 22(3):285.e1-8. PubMed ID: 26548510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.